Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial

Clinical trial NCT07101588 · RECRUITING

Trial details

NCT number: NCT07101588
Sponsor: Chinese PLA General Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Start date: 2025-01-01
Primary completion: 2028-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.